GEN Edge speaks with Codiak Biosciences’ president and CEO Douglas E. Williams, PhD, about how the company has grown from the ground up to develop a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. Codiak designs and engineers exosomes, loads them with various types of therapeutic molecules including nucleic acids and small molecules, and directs them to target and specific cells . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge